Rengelshausen J et al., 2004-10-13: Randomised placebo-controlled pharmacokinetic study of chloroquine with or without 130 mg methylene blue twice daily for three days in 24 healthy volunteers. It documents a 3-day 260 mg/day oral antimalarial regimen and its effect on chloroquine exposure.
with oral co-administration of placebo or 130 mg methylene blue twice daily for 3 days was administered to 24 healthy individuals
Rengelshausen J et al., 2004-10-13: Randomised placebo-controlled pharmacokinetic study of chloroquine with or without 130 mg methylene blue twice daily for three days in 24 healthy volunteers. It documents a 3-day 260 mg/day oral antimalarial regimen and its effect on chloroquine exposure. Study type: randomized trial.
